Shareholders
Ownership structure and shareholding information
Total: 100.00% of shares
| Shareholder Name | Ownership % ↓ | Share Count | Share Type | Date |
|---|---|---|---|---|
| Novo Holdings A/s Company | 21,491,998 | Series F Convertible Preferred | 8 Aug 2025 | |
| Sofinnova Crossover I Slp | 20,368,005 | Series H Convertible Preferred | 8 Aug 2025 | |
| Forbion Growth Opportunities Fund Ii Cooperatief U.a Company | 20,368,005 | Series H Convertible Preferred | 8 Aug 2025 | |
| Morningside Venture Investments Limited Company | 19,019,851 | Series G Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Iii Lp Company | 18,251,564 | Series G Convertible Preferred | 8 Aug 2025 | |
| Novo Holdings A/s Company | 16,208,658 | Series G Convertible Preferred | 8 Aug 2025 | |
| Amr Action Fund L.p Company | 13,948,731 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Icg Life Sciences Scsp | 9,394,350 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Mvil, Llce | 6,752,032 | Series H Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Iii Lp Company | 6,479,290 | Series H Convertible Preferred | 8 Aug 2025 | |
| Novo Holdings A/s Company | 5,652,055 | Series H Convertible Preferred | 8 Aug 2025 | |
| Amr Action Fund, Scsp | 4,839,969 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Novo Holdings A/s Company | 4,697,175 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Morningside Venture Investments Limited Company | 4,403,187 | Series F Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 4,318,200 | Series 1 C Convertible Preferred | 8 Aug 2025 | |
| Sofinnova Crossover I Slp | 4,227,458 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Novo Holdings A/s Company | 4,177,109 | Series E Convertible Preferred | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 3,624,906 | Series F Convertible Preferred | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 3,566,778 | Series G Convertible Preferred | 8 Aug 2025 | |
| Symbiosis Ii, Llc Company | 3,522,881 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 3,461,137 | Series F Convertible Preferred | 8 Aug 2025 | |
| Forbion Growth Opportunities Fund Ii Cooperatief U.a Company | 2,818,305 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Iv Lp Company | 2,719,817 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 2,159,101 | Series 2 C Convertible Preferred | 8 Aug 2025 | |
| Novartis Bioventures Limited Company | 2,013,052 | B Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 1,794,415 | Series D Convertible Preferred | 8 Aug 2025 | |
| Merifin Capital N.v Company | 1,546,722 | Series F Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund Iii Lp Company | 1,541,415 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Merifin Capital N.v Company | 1,511,915 | Series 1 C Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund Iii Lp Company | 1,415,659 | Series G Convertible Preferred | 8 Aug 2025 | |
| Morningside Venture Investments Limited Company | 1,409,153 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund Iii Lp Company | 1,367,169 | Series H Convertible Preferred | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 1,357,561 | Series E Convertible Preferred | 8 Aug 2025 | |
| Ian James Nicholson | 1,223,743 | A Ordinary | 8 Aug 2025 | |
| Sunstone Life Science Ventures A/s Company | 1,095,056 | B Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 1,086,058 | Series E Convertible Preferred | 8 Aug 2025 | |
| Anthony Kennedy | 921,860 | A Ordinary | 8 Aug 2025 | |
| Sunstone Life Science Ventures A/s Company | 856,785 | Ordinary | 8 Aug 2025 | |
| Michael Birch | 835,290 | A Ordinary | 8 Aug 2025 | |
| Emma Harvey | 818,216 | A Ordinary | 8 Aug 2025 | |
| Ralf Schmid | 737,985 | A Ordinary | 8 Aug 2025 | |
| Advent-harrington Impact Fund Lp Company | 553,357 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Ef Iii Lp Company | 511,262 | Series G Convertible Preferred | 8 Aug 2025 | |
| Advent-harrington Impact Fund Lp Company | 477,181 | Series G Convertible Preferred | 8 Aug 2025 | |
| Merifin Capital N.v Company | 468,672 | Series D Convertible Preferred | 8 Aug 2025 | |
| Advent-harrington Impact Fund Lp Company | 465,208 | Series H Convertible Preferred | 8 Aug 2025 | |
| New Emerging Medical Opportunities Fund Iii, Lp Company | 417,711 | B Ordinary | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 375,774 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Merifin Capital N.v Company | 362,174 | Series E Convertible Preferred | 8 Aug 2025 | |
| Sunstone Life Science Ventures A/s Company | 360,433 | A Ordinary | 8 Aug 2025 | |
| Shane Michael Kelly | 360,433 | A Ordinary | 8 Aug 2025 | |
| Merifin Capital N.v Company | 360,433 | A Ordinary | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 271,512 | B Ordinary | 8 Aug 2025 | |
| Merifin Capital N.v Company | 234,859 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Stuart Hadley | 230,465 | A Ordinary | 8 Aug 2025 | |
| Merifin Capital N.v Company | 227,458 | Ordinary | 8 Aug 2025 | |
| Lloyd Payne | 216,390 | A Ordinary | 8 Aug 2025 | |
| David Wemyss Denning | 216,390 | A Ordinary | 8 Aug 2025 | |
| Novartis Bioventures Limited Company | 185,838 | B2 Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 181,800 | Series 1 C Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Ef Iii Lp Company | 181,497 | Series H Convertible Preferred | 8 Aug 2025 | |
| Merifin Capital N.v Company | 179,724 | Series 2 C Convertible Preferred | 8 Aug 2025 | |
| Pawel Jakubowski | 159,375 | A Ordinary | 8 Aug 2025 | |
| Kapil Sony | 153,643 | A Ordinary | 8 Aug 2025 | |
| Astellas Venture Management Llc Company | 152,672 | Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 145,994 | Series F Convertible Preferred | 8 Aug 2025 | |
| Suzanne Lynne Powell | 140,296 | A Ordinary | 8 Aug 2025 | |
| Vink Advisory Services | 140,222 | A Ordinary | 8 Aug 2025 | |
| Half Moon Bay Biotechnology Consulting, Llc Company | 122,614 | A Ordinary | 8 Aug 2025 | |
| Monica Schroeter | 120,938 | A Ordinary | 8 Aug 2025 | |
| Derek Law | 117,824 | A Ordinary | 8 Aug 2025 | |
| Jason David Oliver | 117,121 | A Ordinary | 8 Aug 2025 | |
| Graham Edward Morris Sibley | 117,121 | A Ordinary | 8 Aug 2025 | |
| Takara Leonard | 112,268 | A Ordinary | 8 Aug 2025 | |
| Richard John White | 108,033 | A Ordinary | 8 Aug 2025 | |
| Jeffrey Robertson Edwards | 108,033 | A Ordinary | 8 Aug 2025 | |
| Lesley Fitton | 107,047 | A Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 101,043 | Series H Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 98,649 | Series G Convertible Preferred | 8 Aug 2025 | |
| Blue Owl Healthcare Opportunities Ef Iv Lp Company | 98,488 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Astellas Venture Management Llc Company | 95,848 | Series 2 C Convertible Preferred | 8 Aug 2025 | |
| Brace Pharmaceuticals Llc Company | 95,388 | B2 Ordinary | 8 Aug 2025 | |
| Camilla Soenderby | 93,140 | A Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 90,899 | Series 2 C Convertible Preferred | 8 Aug 2025 | |
| Sylvia Jane Walker | 90,830 | A Ordinary | 8 Aug 2025 | |
| Camilla Soenderby | 76,624 | Series H Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 75,690 | Series D Convertible Preferred | 8 Aug 2025 | |
| Patrick Vink | 75,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Mark Bresnik | 72,020 | A Ordinary | 8 Aug 2025 | |
| Als Iii Carry And Co-invest Lp Company | 65,929 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| Sunstone Life Science Ventures A/s Company | 61,365 | B2 Ordinary | 8 Aug 2025 | |
| Stefan Reisinger | 60,824 | A Ordinary | 8 Aug 2025 | |
| Als Iii Carry And Co-invest Lp Company | 60,550 | Series G Convertible Preferred | 8 Aug 2025 | |
| Als Iii Carry And Co-invest Lp Company | 58,476 | Series H Convertible Preferred | 8 Aug 2025 | |
| Linda Morley | 54,179 | A Ordinary | 8 Aug 2025 | |
| John Thain | 54,179 | A Ordinary | 8 Aug 2025 | |
| K Nominees Limited Company | 53,756 | Ordinary | 8 Aug 2025 | |
| Steven James Lomax | 50,280 | A Ordinary | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 45,811 | Series E Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Fund I Lp Company | 45,071 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| K Nominees Limited Company | 44,703 | Series 1 C Convertible Preferred | 8 Aug 2025 | |
| Robert Dwyer Peter Nolan | 43,148 | A Ordinary | 8 Aug 2025 | |
| K Nominees Limited Company | 41,502 | Series 2 C Convertible Preferred | 8 Aug 2025 | |
| Graham Edward Morris Sibley | 41,096 | Series G Convertible Preferred | 8 Aug 2025 | |
| Graham Edward Morris Sibley | 40,867 | Series H Convertible Preferred | 8 Aug 2025 | |
| Dean Thompson | 40,000 | A Ordinary | 8 Aug 2025 | |
| Graham Edward Morris Sibley | 32,787 | Series F Convertible Preferred | 8 Aug 2025 | |
| Julie Gould | 21,736 | A Ordinary | 8 Aug 2025 | |
| Mihovil Spoljaric | 20,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Ian James Nicholson | 20,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Geoffrey Ross | 20,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Anthony Kennedy | 20,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Michael Bonney | 16,667 | Series G Convertible Preferred | 8 Aug 2025 | |
| Michael Birch | 16,394 | Series F Convertible Preferred | 8 Aug 2025 | |
| Michael Birch | 15,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| John Howard Rex | 15,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Richard John White | 13,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Katharine Dobb | 10,706 | A Ordinary | 8 Aug 2025 | |
| Joanne Goodwin | 10,706 | A Ordinary | 8 Aug 2025 | |
| Sufyaan Bhamjee | 10,216 | Series H Convertible Preferred | 8 Aug 2025 | |
| Stefan Reisinger | 10,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| John Howard Rex | 10,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Ian James Nicholson | 10,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Christian Fabsich | 10,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Anthony Kennedy | 10,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Jason David Oliver | 8,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Ralf Schmid | 7,500 | Series G Convertible Preferred | 8 Aug 2025 | |
| Jason David Oliver | 7,500 | Series G Convertible Preferred | 8 Aug 2025 | |
| Stefan Reisinger | 7,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Angela Wardman | 7,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Suzanne Lynne Powell | 6,850 | Series G Convertible Preferred | 8 Aug 2025 | |
| Emma Harvey | 6,850 | Series G Convertible Preferred | 8 Aug 2025 | |
| Angela Wardman | 6,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Emma Harvey | 5,108 | Series H Convertible Preferred | 8 Aug 2025 | |
| Ann Walkden | 5,100 | Series H Convertible Preferred | 8 Aug 2025 | |
| Suzanne Lynne Powell | 5,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Stuart Hadley | 5,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Stuart Hadley | 5,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Stefan Reisinger | 5,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Ralf Schmid | 5,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Lesley Fitton | 5,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Derek Law | 5,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Claudia Lell | 4,300 | Series H Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 4,262 | Series H Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 4,161 | Series G Convertible Preferred | 8 Aug 2025 | |
| Karen Cornelissen | 4,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Corinne Pinder | 4,000 | Series G Convertible Preferred | 8 Aug 2025 | |
| Steven James Lomax | 3,500 | Series F Convertible Preferred | 8 Aug 2025 | |
| Claudia Lell | 3,500 | Series G Convertible Preferred | 8 Aug 2025 | |
| Ana Zaccaro | 3,064 | Series H Convertible Preferred | 8 Aug 2025 | |
| Lesley Fitton | 3,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Karen Cornelissen | 3,000 | Series F Convertible Preferred | 8 Aug 2025 | |
| Derek Law | 2,750 | Series G Convertible Preferred | 8 Aug 2025 | |
| Nicola Beckmann | 2,500 | A Ordinary | 8 Aug 2025 | |
| Stuart Hadley | 2,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Jason David Oliver | 2,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Advent Life Sciences Llp Company | 1,901 | Series H1 Convertible Preferred | 8 Aug 2025 | |
| David Wemyss Denning | 1,845 | Ordinary | 8 Aug 2025 | |
| Jayne Louise Brookman | 1,540 | Ordinary | 8 Aug 2025 | |
| Toni Wilson | 1,532 | Series H Convertible Preferred | 8 Aug 2025 | |
| Sylvia Jane Walker | 1,500 | Series F Convertible Preferred | 8 Aug 2025 | |
| Suzanne Lynne Powell | 1,250 | Series F Convertible Preferred | 8 Aug 2025 | |
| Ressa Sinaia Lebedinec Radigues | 1,021 | Series H Convertible Preferred | 8 Aug 2025 | |
| Kapil Sony | 1,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Dean Thompson | 1,000 | Series H Convertible Preferred | 8 Aug 2025 | |
| Ashley Stephen Charles Cooper | 700 | Ordinary | 8 Aug 2025 | |
| Fungal Infection Trust Company | 665 | Ordinary | 8 Aug 2025 | |
| Sarah Virginia Catherine Gissane | 500 | Ordinary | 8 Aug 2025 | |
| Elizabeth Gossett Karaman | 295 | Ordinary | 8 Aug 2025 | |
| John Charles Morgan | 258 | Ordinary | 8 Aug 2025 | |
| Adrian Bennett | 177 | Ordinary | 8 Aug 2025 | |
| Geoffrey Smith | 120 | Ordinary | 8 Aug 2025 | |
| Wendy Elizabeth Denning | 102 | Ordinary | 8 Aug 2025 | |
| Walter Bruce Gossett | 102 | Ordinary | 8 Aug 2025 | |
| Jennifer Joy Denning | 102 | Ordinary | 8 Aug 2025 | |
| Catherine Ann Walker | 102 | Ordinary | 8 Aug 2025 | |
| John Coulter Gossett | 101 | Ordinary | 8 Aug 2025 | |
| Sid Gould | 82 | Ordinary | 8 Aug 2025 | |
| Jean Bertha Gould | 71 | Ordinary | 8 Aug 2025 | |
| A D Sturrock & S Birkinshaw | 71 | Ordinary | 8 Aug 2025 | |
| Lawrence Jonathon Gould | 53 | Ordinary | 8 Aug 2025 | |
| Aea Management Inc Company | 43 | Ordinary | 8 Aug 2025 | |
| Benjamin Marks | 36 | Ordinary | 8 Aug 2025 | |
| Mark Mitchell | 35 | Ordinary | 8 Aug 2025 | |
| J M Gittins | 35 | Ordinary | 8 Aug 2025 | |
| Deborah Marks | 35 | Ordinary | 8 Aug 2025 | |
| Daniel Marks | 35 | Ordinary | 8 Aug 2025 | |
| Charles David Cranmer | 35 | Ordinary | 8 Aug 2025 | |
| Anthony Ward Rhodes | 29 | Ordinary | 8 Aug 2025 | |
| Serena Simmons | 25 | Ordinary | 8 Aug 2025 | |
| Mari Roberts | 22 | Ordinary | 8 Aug 2025 | |
| Simon Hilary Gould | 21 | Ordinary | 8 Aug 2025 | |
| Matthew Steven Gould | 21 | Ordinary | 8 Aug 2025 | |
| Olivia Williams | 20 | Ordinary | 8 Aug 2025 | |
| John Tarling | 20 | Ordinary | 8 Aug 2025 | |
| Anthony Soar | 18 | Ordinary | 8 Aug 2025 | |
| Elizabeth Llewelyn Jones | 17 | Ordinary | 8 Aug 2025 | |
| Howard Cole | 12 | Ordinary | 8 Aug 2025 | |
| William Thomas Alexander Gissane | 10 | Ordinary | 8 Aug 2025 | |
| Elizabeth Anne Catherine Oldham | 10 | Ordinary | 8 Aug 2025 | |
| Nora Erin Penney Cole | 6 | Ordinary | 8 Aug 2025 | |
| Devan Cole Penney | 6 | Ordinary | 8 Aug 2025 |